
Request for FDA EUA for Linea™ 2.0 COVID-19 Assay, Linea™ Unsupervised At-Home Sample Collection Kit
January 21st, 2022
Request for FDA EUA for Linea™ 2.0 COVID-19 Assay, Linea™ Unsupervised At-Home Sample Collection Kit
January 21st, 2022
APDN’s COVID-19 Diagnostic Kit Granted FDA EUA Amendment
August 3rd, 2020
COVID-19 Diagnostic Kit Testing Capacity Increased by FDA EUA Amendment
July 31st, 2020
Applied DNA Forms Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea™ COVID-19 Assay Kit and Expands Utility with Successful EUA Amendment
July 9th, 2020
New Highly Sensitive COVID-19 Clinical Test Now in Use at Stony Brook
May 18th, 2020
FDA grants EUA for COVID-19 molecular tests
May 18th, 2020
APDN Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
May 15th, 2020
Applied DNA launches RT-PCR test for COVID-19
May 14th, 2020
Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
May 14th, 2020